TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Lawrence N Shulman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.